February 4, 2015
Alliqua BioMedical, Inc to Acquire Celleration
Alliqua BioMedical, Inc (Langhorne, PA) announced that it has signed a definitive agreement to acquire Celleration, Inc.
View Article: WOUNDS
July 25, 2014
Chutes and Ladders
Alliqua BioMedical has announced the appointment of Andrew Africk and Gary Restani to its board of directors.
View Article: Fierce Biotech
May 8, 2014
Wrentham wound care business bought by Alliqua for $4M
A Wrentham company that makes an antimicrobial wound dressing has become the first acquisition of Pennsylvania-based Alliqua, but probably not the last.
View Article: Boston Business Journal
May 6, 2014
Wound-care companies merge in $4M deal
Alliqua Inc. has acquired Choice Therapeutics for about $4 million in cash and stock in a deal involving two wound-care companies.
View Article: Philadelphia Business Journal
April 7, 2014
Alliqua Biomedical’s Advances in Wound Dressings Can Save Lives and Limbs
It is a stunning and frightening statistic: every 30 seconds somewhere in the world a person is losing a limb to diabetes.
View Article: Information About Diabetes
January 28, 2014
Alliqua Roll Continues With Nasdaq Listing
Alliqua’s listing on NASDAQ this week will increase the wound care provider’s visibility in the market, and ultimately increase its shareholder base, says the company’s CEO David Johnson.
View Video: The Street
January 27, 2014
Wound Care Company Graduating to NASDAQ
A Langhorne, Pa., wound-care company has received approval from NASDAQ’s Listing Qualifications Department to list its common stock on the NASDAQ Capital Market.
View Article: Philadelphia Business Journal
January 7, 2014
State of the Art Hydrogels for Wound Care and Drug Delivery: Interview with CEO of Alliqua
Medgadget interviews David Johnson to learn about the latest products offered by the company and to get a better understanding of the next generation of wound care tools.
View Article: MedGadget
December 31, 2013
Top Chiefs Want You To Collaborate, Click In 2014
Alliqua recently partnered with Germany-based Sorbion to exclusively distribute that firm’s wound care products, such as high-tech dressings that prevent infection, throughout the Americas.
View Article: Investor’s Business Daily
December 10, 2013
Alliqua CEO: Celgene Deal Vaults Us to ‘Another Level of Respectability’
FierceDrugDelivery spoke to Alliqua CEO David Johnson about what the company hopes to gain and where it goes from here.
View Article: Fierce Drug Delivery
November 19, 2013
Wound Care Licensing Deal with Celgene Latest Development in Biopharma’s Evolution
Alliqua Biomedical has supplemented its wound care business in a $6 million licensing deal with Celgene’s cellular therapuetics division.
View Article: MedCity News
November 17, 2013
Hydrogels: Building a Better Wound Dressing
Hydrogel dressings are designed to rehydrate the wound bed and reduce wound pain. They can be used on infected wounds and with topical medications.
View Article: Medical Design Technology
November 10, 2013
CEO Spotlight: David Johnson of Alliqua
I love working with very smart and innovative people. I love building something the marketplace needs — it is more fun and energizing to build something rather than tear things down.
View Article: Ostomy Wound Management
November 2013
Hydrogels: A Key Element for Next-Generation Dressings
Alliqua is focusing on hydrogels as a key to superior dressings, and harnessing them in two innovative wound dressings knowns as SilverSeal and Hydress.
View Article: Western Pennsylvania Healthcare News
September 24, 2013
Reinventing the Bandage with Hydrogels
It’s not often that a contract manufacturer enters the medical device market. Alliqua Inc. has made that jump, and has re-imagined itself as a maker of wound-care products.
View Article: Qmed
September 19, 2013
Alliqua CEO: Hydrogel-Based Transdermal Drug Delivery, An Innovative Alternative
Transdermal drug delivery (TDD) represents an attractive alternative to other drug delivery methods and an increasingly promising player in the $142 billion drug delivery market.
View Article: Drug Discovery & Development
September 18, 2013
Biopharm Company Gets New Home, New Focus
Bucks County has a new publicly traded biopharmaceutical company, which is out to grab a chunk of the $6 billion wound-care industry.
View Article: Philadelphia Business Journal
September 09, 2013
Lidocaine Hydrogel Patches Will Be Developed to Treat Localized Acute Pain
US-based wound management and drug delivery company Alliqua is launching a preclinical proof-of-principle study of an experimental hydrogel transdermal patch containing lidocaine.
View Article: Manufacturing Chemist
August 02, 2013
NewCo on the Go: Alliqua CEO Touts Milestones of the ‘Vibrant Little Company’
Alliqua, a wound management and drug delivery company, has seen a lot of changes in the past six months, starting at the top.
View Article: Medical Device Daily
